Liver Function Testing Is Not Helpful for Early Diagnosis of Metastatic Uveal Melanoma

被引:18
作者
Mouriaux, Frederic [1 ,2 ,3 ]
Diorio, Caroline [4 ,5 ]
Bergeron, Dan [1 ,2 ]
Berchi, Celia [6 ]
Rousseau, Alain [1 ,2 ]
机构
[1] Hop St Sacrement, CHA, Ctr Univ Ophtalmol, Quebec City, PQ, Canada
[2] Univ Laval, Fac Med, Dept Ophtalmol, Quebec City, PQ G1K 7P4, Canada
[3] CHU Caen, Dept Ophtalmol, F-14000 Caen, France
[4] Hop St Sacrement, CHA, Ctr Rech FRSQ CHA, URESP, Quebec City, PQ, Canada
[5] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ G1K 7P4, Canada
[6] Univ Caen, CHU Caen, INSERM Canc & Populat ERI3, F-14032 Caen, France
关键词
COLLABORATIVE OCULAR MELANOMA; CHOROIDAL MELANOMA; SURVIVAL; DISEASE; COMS; MONOSOMY-3;
D O I
10.1016/j.ophtha.2012.01.045
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To study the relevance of liver function test (LFT) results for early detection of liver metastasis of uveal melanoma. Design: Evaluation of diagnostic test. Participants: Eighty-eight patients were included in whom metastasis developed while undergoing semiannual follow-up with LFTs, including aspartate-aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyltransferase (gamma GT), lactate dehydrogenase (LDH), and phosphatase alkaline (PA). As controls, 174 patients with uveal melanoma without metastasis were included. Methods: The diagnostic attributes of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for each test were estimated from cross-tabulation tables of test results according to the diagnosis of metastasis. The proportions of false-positive results between groups of patients with and without metastasis were compared in log-binomial regression models. Main Outcome Measures: Sensitivity, specificity, PPV, NPV, and cost evaluation. Results: Metastases were detected after LFT abnormality (at least 1 abnormal test result) in 40 (45%) patients. The overall sensitivity of LFTs ranged from 12.5% to 58.0%, and the PPV ranged from 9.4% to 38.6%. The overall specificity and NPV were 90% or greater. The proportions of false-positive results between groups of patients with and without metastasis did not differ significantly (all P >= 0.38). Using a cost evaluation, semi-annual screening by LFTs was calculated to cost $35.5/year per patient, including liver imaging induced by true and false-positive results. Conclusions: Isolated or combined LFTs for AST, ALT, gamma GT, LDH, and PA are not helpful for detection of early metastasis. However, the high NPVs suggest that LFT screening can allow clinicians to reassure the patient when the LFT results are negative. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article. Ophthalmology 2012;119:1590-1595 (C) 2012 by the American Academy of Ophthalmology.
引用
收藏
页码:1590 / 1595
页数:6
相关论文
共 27 条
[1]   Surveillance Testing for Metastasis From Primary Uveal Melanoma and Effect on Patient Survival [J].
Augsburger, James J. ;
Correa, Zelia M. ;
Trichopoulos, Nikolaos .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 152 (01) :5-9
[2]   Molecular pathways mediating liver metastasis in patients with uveal melanoma [J].
Bakalian, Silvin ;
Marshall, Jean-Claude ;
Logan, Patrick ;
Faingold, Dana ;
Maloney, Shawn ;
Di Cesare, Sebastian ;
Martins, Claudia ;
Fernandes, Bruno F. ;
Burnier, Miguel N., Jr. .
CLINICAL CANCER RESEARCH, 2008, 14 (04) :951-956
[3]   Developments in the management of uveal melanoma [J].
Damato, B .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 32 (06) :639-647
[4]   Prognostic factors for malignant uveal melanoma. Retrospective study on 2,241 patients and recent contribution of monosomy-3 research [J].
Desjardins, L. ;
Levy-Gabriel, C. ;
Lumbroso-Lerouic, L. ;
Sastre, X. ;
Dendale, R. ;
Couturier, J. ;
Piperno-Neumann, S. ;
Dorval, T. ;
Mariani, P. ;
Salmon, R. ;
Plancher, C. ;
Asselain, B. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2006, 29 (07) :741-749
[5]  
Diener-West M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1639
[6]   Screening for metastasis from choroidal melanoma: The Collaborative Ocular Melanoma Study Group report 23 [J].
Diener-West, M ;
Reynolds, SM ;
Agugliaro, DJ ;
Caldwell, R ;
Cumming, K ;
Earle, JD ;
Green, DL ;
Hawkins, BS ;
Hayman, J ;
Jaiyesimi, I ;
Kirkwood, JM ;
Koh, WJ ;
Robertson, DM ;
Shaw, JM ;
Thoma, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2438-2444
[7]   METASTATIC UVEAL MELANOMA - PRETHERAPY SERUM LIVER-ENZYME AND LIVER-SCAN ABNORMALITIES [J].
DONOSO, LA ;
BERD, D ;
AUGSBURGER, JJ ;
MASTRANGELO, MJ ;
SHIELDS, JA .
ARCHIVES OF OPHTHALMOLOGY, 1985, 103 (06) :796-798
[8]  
Eskelin S, 1999, CANCER-AM CANCER SOC, V85, P1151, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1151::AID-CNCR20>3.3.CO
[9]  
2-7
[10]   A prognostic model and staging for metastatic uveal melanoma [J].
Eskelin, S ;
Pyrhönen, S ;
Hahka-Kemppinen, M ;
Tuomaala, S ;
Kivelä, T .
CANCER, 2003, 97 (02) :465-475